Selective serotonin reuptake inhibitors: A review of its effects on intraocular pressure

Current Neuropharmacology

Volumn 6, Issue 4, 2008, Pages 293-310

  Costagliola, Ciro ^a   Parmeggiani, Francesco ^b   Semeraro, Francesco ^c   Sebastiani, Adolfo ^b  

^a UNIVERSITY OF MOLISE   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Citalopram; Escitalopram; Fluoxetine; Fluvoxamine; Intraocular pressure; Paroxetine; Sertraline; Side effects

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; 5 CARBAMOYLTRYPTAMINE; 5 METHYLURAPIDIL; 5,6 DIHYDROXYTRYPTAMINE; CITALOPRAM; DOPAMINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; KETANSERIN; METHYSERGIDE; MIANSERIN; NEUROTRANSMITTER RECEPTOR; NORADRENALIN; PAROXETINE; SEROTONIN; SEROTONIN 1 RECEPTOR; SEROTONIN 1A AGONIST; SEROTONIN 2 RECEPTOR; SEROTONIN 3 RECEPTOR; SEROTONIN 4 RECEPTOR; SEROTONIN 5 RECEPTOR; SEROTONIN 6 RECEPTOR; SEROTONIN 7 RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TIMOLOL; TOPIRAMATE; UNINDEXED DRUG;

CATARACT; CHOROID DISEASE; CLOSED ANGLE GLAUCOMA; DEPRESSION; DRUG BINDING SITE; DRUG EFFICACY; DRUG RECEPTOR BINDING; DRUG SAFETY; EPILEPSY; EYE DISEASE; GLAUCOMA; HUMAN; HYPERMETROPIA; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; INTRAOCULAR PRESSURE ABNORMALITY; MAJOR DEPRESSION; MYDRIASIS; NEUROTRANSMISSION; NONHUMAN; OPEN ANGLE GLAUCOMA; OPTIC NERVE DISEASE; PATHOPHYSIOLOGY; PRESYNAPTIC INHIBITION; PROTEIN FAMILY; REVIEW; SIDE EFFECT; UVEA DISEASE; VISUAL DISORDER; VITREOUS BODY DETACHMENT;

EID: 66149087742     PISSN: 1570159X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157015908787386104     Document Type: Review

References (145)

1. Abdel Latif, A.A. (1996) Cross talk between cyclic AMP and the polyphosphoinositide signaling cascade in iris sphincter and other nonvascular smooth muscle. Proc. Soc. Exp. Biol. Med., 211, 163-177.
2. Abe, M., Itoh, M.T., Miyata, M., Ishikawa, S., Sumi, Y. (1999) Detection of melatonin, its precursors and related enzyme activities in rabbit lens. Exp. Eye Res., 68, 255-262.
3. 7(a) receptor isoform coupled to adenylate cyclase stimulation. J. Pharmacol. Exp. Ther., 287, 508-514.
4. Ahmad, S. (1991) Fluoxetine and glaucoma. Ann. Pharmacother. (DICP), 25, 436.
5. 4 turnover in rabbit cornea. Exp. Eye Res., 44, 849-862.
6. 1A receptor gene. J. Biol. Chem., 265, 5825-5832.
7. Alfaro, C.L., Lam, Y.W., Simpson, J., Ereshefsky, L. (1999) CYP2D6 status of extensive metabolizers after multiple-dose fluoxetine, fluvoxamine, paroxetine, or sertraline. J. Clin. Psychopharmacol., 19, 155-163.
8. Auricchio, G., Barany, E.H. (1959) On the role of osmotic water transport in the secretion of aqueous humor. Acta Physiol. Scand., 45, 190-210.
9. Barbaccia, M.L., Brunello, N., Chuang, E., Costa, E. (1983) Serotonin elicited amplification of adenylate cyclase activity in hippocampal membranes from adult rat. J. Neurochem., 40, 1671-1679.
10. 1) receptors negatively coupled to adenylate cyclase in rabbit and human iris-ciliary processes. Exp. Eye Res., 57, 209-216.
11. Becker, B. (1959) Carbonic anhydrase and the formation of aqueous humor. Am. J. Ophthalmol., 47, 342-361.
12. Bennett, H.G., Wyllie AM. (1999) Paroxetine and acute angle-closure glaucoma. Eye, 13, 691-692.
13. Bill, A., Barany, E.H. (1966) Gross facility, facility of conventional routes and pseudofacility of aqueous humor outflow in the cynomolgus monkey. Arch. Ophthalmol., 75, 665-673.
14. Boerrigter, R.M., Siertsema, J.V., Kema, I.P. (1992) Serotonin (5-HT) and the rat's eye. Some pilot studies. Doc. Ophthalmol., 82, 141-150.
15. Boles, Carenini, B., Brogliatti, B. (1996) Intraocular pressure as a risk factor in glaucoma. In: Bucci, M.G. Ed. Glaucoma: decision making in therapy. Milan: Springer-Verlag, pp. 9-14
16. Bonomi. L., Marchini, G., Marraffa, M., Bernardi, P., De Franco, I., Perfetti, S., Varotto, A., Tenna, V. (1998) Prevalence of glaucoma and intraocular pressure distribution in a defined population. The Egna-Neumarkt Study. Ophthalmology, 105, 209-215.
17. Bonomi, L., Marchini, G., Marraffa, M., Bernardi, P., De Franco I., Perfetti S., Varotto A. (2000) Epidemiology of angle-closure glaucoma: prevalence, clinical types, and association with peripheral anterior chamber depth in the Egna-Neumarket Glaucoma Study. Ophthalmology, 107, 998-1003.
18. Browning AC, Reck AC, Chisholm IH, Nischal KK. (2000) Acute angle closure glaucoma presenting in a young patient after administration of paroxetine. Eye, 14, 406-408.
19. Brunken, W.J, Daw, N.W. (1988) The effects of serotonin agonists and antagonists on the response properties of complex ganglion cells in the rabbit's retina. Vis. Neurosci., 1, 181-188.
20. 3 receptors in visual processing in the mammalian retina. Vis. Neurosci., 10, 511-522.
21. Brunken, W.J., Jin, X.T, Pis-Lopez, A.M. (1993) The properties of the serotonergic system in the retina. Prog. Ret. Res., 16, 75-99.
22. Buckley, C., Hadoke, P.W., Henry, E., O'Brien, C. (2002) Systemic vascular endothelial cell dysfunction in normal pressure glaucoma. Br. J. Ophthalmol., 86, 227-232.
23. Cadieux, R.J. (1999) Antidepressant drug interactions in the elderly. Understanding the P-450 system is half the battle in reducing risks. Postgrad. Med., 106, 231-232.
24. Candia, O.A., Lanzetta, P.A., Alvarez, L.J., Gaines, W. (1980) Inhibition of ionic transport and ATPase activities by serotonin analogues in the isolated toad lens. Biochim. Biophys. Acta 602, 389-400.
25. Chafetz. M.D. (1990) Nutrition and neurotransmitters: the nutrient bases of behavior. Englewood Cliffs: Prentice Hall, Inc.
26. Chang, F.W., Burke, J.S., Potter. D.E. (1985) Mechanism of the ocular hypotensive action of ketanserin. J. Ocular. Pharmacol., 1, 137-147.
27. Chidlow, G., De Santis, L, M., Sharif, N, A., Osborne, N, N. (1995) Characteristics of [3H]5-hydroxytryptamine binding to irisciliary body tissue of the rabbit. Invest. Ophthalmol. Vis. Sci. 36, 2238-2245.
28. 7 receptors in rabbit ocular and brain tissues. Neuroscience, 87, 675-689.
29. (1A)Receptor agonist 8-OH-DPAT lowers intraocular pressure in normotensive NZW rabbits. Exp. Eye Res., 69, 587-593.
30. Christensen, L. (1997) The effect of carbohydrates on affect. Nutrition, 13, 503-514.
31. Cohen, Z., Bonvento, G. Lacombe, P., Hamel, E. (1996) Serotonin in the regulation of brain microcirculation. Prog. Neurobiol., 50, 335-362.
32. Congdon, N., Wang, F,, Tielsch, J.M.(1992) Issues in the epidemiology and population-based screening of primary angle-closure glaucoma. Surv. Ophthalmol., 36, 411-423.
33. Costagliola, C., Campa, C., Parmeggiani, F., Incorvaia, C, Perri, P., D'Angelo S., Lamberti, G., Sebastiani, A. (2007) Effect of 2% dorzolamide on retinal blood flow: a study on juvenile primary open-angle glaucoma patients already receiving 0.5% timolol. Br. J. Clin. Pharmacol., 63, 376-379.
34. Costagliola, C., Fasano, M.L., Iuliano, G., Ferrara LA. (1990) Effect of ketanserin on intraocular pressure. Cardiovasc. Drug Ther., 4, 95-97.
35. Costagliola, C., Iuliano, G., Rinaldi, M., Russo, V., Scibelli, G,, Mastropasqua, L. (1993) Effect of topical ketanserin administration on intraocular pressure. Br. J. Ophthalmol., 77, 344-348.
36. Costagliola, C., Mastropasqua, L., Capone, D., Verolino, M., Ciancaglini, M., Pisanti, N. (2000) Effect of fluoxetine on intraocular pressure in the rabbit. Exp. Eye Res., 70, 551-555.
37. Costagliola, C., Mastropasqua, L., Steardo, L., Testa, N. (1996) Fluoxetine oral administration increases intraocular pressure. Br. J. Ophthalmol., 80, 678.
38. Costagliola, C., Parmeggiani, F., Virgili, G., Lamberti, G., Incorvaia, C., Perri, P., Campa, C., Sebastiani, A. (2008) Circadian changes of intraocular pressure and ocular perfusion pressure after timolol or latanoprost in Caucasians with normal-tension glaucoma. Graefes Arch. Clin. Exp. Ophthalmol., 246, 389-396.
39. Croos, R., Thirumalai., S, Hassan, S., Davis, Jda R. (2005) Citalopram associated with acute angle-closure glaucoma: case report. BMC Ophthalmol., 5, 23.
40. Davies, M.G., Hagen, P.O. (1993) The vascular endothelium. A new horizon. Ann. Surg., 218, 593-609.
41. Davson, H. (1980) Physiology of the aqueous humor. In: Davson, H., Ed. Physiol. eye. London: Churchill Livingstone, pp. 9-82.
42. 1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture. Mol. Pharmacol., 33, 176-186.
43. Dumuis, A., Bouhelal, R., Sebben, M., Cory, R., Bockaert, J. (1988) A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system. Mol. Pharmacol., 34, 880-887.
44. 7 receptor: orphan found. Trends Pharm. Sci., 18, 104-107.
45. Ehinger, B., Holmgren, I. (1979) Electron microscopy of the indoleamine accumulating neurons in the rabbit retina. Cell Tissue Res., 197, 175-194.
46. Eke, T., Bates, A.K. (1997) Acute angle closure glaucoma associated with paroxetine. BMJ,. 314, 1387.
47. Ericson, L.A. (1958) Twenty-four hourly variations of the aqueous flow. Examination with perilimbal suction cup. Acta Ophthalmol., 50, 1-95.
48. European Glaucoma Society. Terminology and guidelines for glaucoma. Savona: Editrice DOGMA® S.r.l., 2003.
49. Flammer, J., Orgül, S., Costa, V.P., Orzalesi, N., Krieglstein, G.K., Serra, L.M., Renard, J.P., Stefánsson, E. (2002) The impact of ocular blood flow in glaucoma. Prog. Retin. Eye Res., 21, 359-393.
50. Fraunfelder, F.W., Fraunfelder. F.T., Keates, E.U. (2004) Topiramate associated acute, bilateral, secondary angle-closure glaucoma. Ophthalmology, 111, 109-111.
51. Glennon, R.A., Dukat, M. (2002) Serotonin receptors and drugs affecting serotonergic neurotransmission. In: Williams, D.A., Lemke, T. Eds. Foye's textbook of medical chemistry. Baltimore: Williams and Wilkins Inc., pp. 315-37.
52. Goldmann, H. (1968) On pseudofacility. Bibl. Ophthalmol., 76, 1-14.
53. Golino, P., Crea, F., Willerson, J.T. (2002) How to study the effects of platelet aggregation and thrombosis on coronary vasomotion and their clinical relevance. Ital. Heart J., 3, 220-225
54. Gondim, E.L., Liu, J.H., Costa, V.P., Weinreb, R.N. (2001) Exogenous vasopressin influences intraocular pressure via the V(1) receptors. Curr. Eye Res., 22, 295-303.
55. Greenblatt, D.J., von Moltke, L.L., Harmatz, J.S., Shader, R.I. (1999) Human cytochromes and some newer antidepressants: kinetics, metabolism, and drug interactions. J. Clin. Psychopharmacol., 19, 23S-35S.
56. Grueb, M., Wallenfels-Thilo, B,, Denk, O., Mielke, J., Reinthal, E., Rohrbach, J.M., Bartz-Schmidt, K, U. (2006) Monoamine receptors in human corneal epithelium and endothelium. Acta Ophthalmol. Scand., 84, 110-115.
57. Haefliger, I.O., Flammer, J., Luscher, T.F. (1993) Heterogeneity of endothelium-dependent regulation in ophthalmic and ciliary arteries. Invest. Ophthalmol. Vis. Sci., 34, 1722-1730.
58. Hansen, M.B., Jaffe, B.M. (1994) 5-HT receptor subtypes involved in luminal serotonin-induced secretion in rat intestine in vivo. J. Surg. Res., 56, 277-287.
59. Hayreh, S.S. (1962) The ophthalmic artery. III Branches. Br. J. Ophthalmol., 46, 212-247.
60. Hayreh, S.S. (1999) Retinal and optic nerve head ischemic disorders and atherosclerosis: role of serotonin. Prog. Retin. Eye Res., 18, 191-221.
61. Hayreh, S.S. (2001) The optic supply of the optic nerve head and the evaluation of it. Myth and reality. Prog. Retin. Eye Res., 20, 563-593.
62. Hayreh, S.S., Piegors, D.J, Heistad, D.D. (1997) Serotonin-induced constriction of ocular arteries in atherosclerotic monkeys. Implications for ischemic disorders of the retina and optic nerve head. Arch. Ophthalmol., 115, 220-228.
63. Hayreh, S.S., Zimmerman, M.B., Podhajsky, P., Alward, W.L. (1994) Nocturnal hypotension and its role in optic nerve head and ocular ischemic disorders. Am. J. Ophthalmol., 117, 603-624.
64. 1C serotonin receptor binding. J. Med. Chem., 35, 4903-4910.
65. Holland, M.G., Gipson, C.C. (1970) Chloride ion transport in isolated ciliary body. Invest. Ophthalmol., 9, 20-29.
66. Hoyer, D., Hannon, J.P., Martin, G.R. (2002) Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol. Biochem. Behav., 71, 533-554.
67. Humphrey, P.P.A., Hartig, P.R., Hoyer, D. (1993) A new nomenclature for 5-HT receptors. Trends Pharmacol. Sci., 14, 233-236.
68. Hyde, J.S., Mezulis, A.H, Abramson, L.Y. (2008) The ABCs of depression: integrating affective, biological, and cognitive models to explain the emergence of the gender difference in depression. Psychol. Rev., 115, 291-313.
69. Jimenez-Jimenez, F.J., Orti-Pareja, M., Zurdo, J.M. (2001) Aggravation of glaucoma with fluvoxamine. Ann. Pharmacother., 35, 1565-1566.
70. Kaiser, H.J., Flammer, J., Graf, T., Stuempfig, D. (1993) Systemic blood pressure in glaucoma patients. Graefes Arch. Clin. Exp. Ophthalmol., 231, 677-680.
71. Kirwan, J.F., Subak-Sharpe, I.., Teimory, M. (1997) Bilateral acute angle closure glaucoma after administration of paroxetine. Br. J. Ophthalmol., 81, 252.
72. Kitazawa, Y., Horie, T. (1975) Diurnal variation of intraocular pressure in primary open-angle glaucoma. Am. J. Ophthalmol., 79, 557-566.
73. Klyce, S.D, Palkama, K.A., Harkonen, M., Marshall, W.S., Huhtaniitty, S., Mann, K.P, Neufeld, A.H. (1982) Neural serotonin stimulates chloride transport in rabbit corneal epithelium. Invest. Ophthalmol. Vis. Sci., 23, 181-192.
74. Kramer, M., Reines, S. (1995) Oral imipramine and acute angle-closure glaucoma. Arch. Ophthalmol., 113, 698-689.
75. Krootila, K., Palkama, A., Uusitalo, H. (1987) Effect of serotonin and its antagonist (ketanserin) on intraocular pressure in the rabbit. J. Ocular Pharmacol., 3, 279-290.
76. Krupin, T., Civan, M.M. (1996) Physiologic basis of aqueous humor formation. In: Ritch, R., Shields, M.B., Krupin, T., Eds. The glaucomas: clinical science (2nd edition). St. Louis: Mosbly-Year Book, Inc., Vol. 1; pp. 251-80.
77. Lane, R.M. (1997) SSRIs and hyponatraemia. Br. J. Clin. Pract., 51, 144-146.
78. 3 antagonist. Fundam. Appl. Toxicol., 27, 270-276.
79. Levy, J., Tessler, Z., Klemperer, I., Shneck, M., Lifshitz, T. (2004) Late bilateral acute angle-closure glaucoma after administration of paroxetine in a patient with plateau iris configuration. Can. J. Ophthalmol., 39, 780-781.
80. Lewis, C.F., DeQuardo, J.R., DuBose, C., Tandon, R. (1997) Acute angle-closure glaucoma and paroxetine. J. Clin. Psychiatry, 58, 123-124.
81. Lieberman, E., Stoudemire, A. (1987) Use of tricyclic antidepressants in patients with glaucoma. Assessment and appropriate precautions. Psychosomatics, 28, 145-148.
82. 7) implicate din the regulation of mammalian circadian rhythms. Neuron, 11, 449-458.
83. Lutjen-Drecoll, E., Shimizu, T., Rohrbach, M., Rohen, J.W. (1986) Quantitative analysis of 'plaque material' in the inner- and outer wall of Schlemm's canal in normal- and glaucomatous eyes. Exp, Eye Res., 42, 443-455.
84. Mallorga, P., Sugrue, M.F. (1987) Characterization of serotonin receptors in the iris+ciliary body of the albino rabbits. Curr. Eye Res., 6, 527-532.
85. Martin, X.D, Malina, H.Z., Brennan, M.C, Hendrickson, P.H., Lichter, P.R. (1992) The ciliary body: the third organs found to synthesize indoleamines in humans. Eur. J. Ophthalmol., 2, 67-72.
86. Massaoutis, P., Goh, D., Foster, P.J. (2007) Bilateral symptomatic angle closure associated with a regular dose of citalopram, an SSRI antidepressant. Br. J. Ophthalmol., 91, 1086-1087.
87. Mastropasqua, L., Ciancaglini, M., Carpineto, P., Costagliola, C. (1997) Ocular hypotensive effect of topical ketanserin in timolol users. Graefes Arch, Clin. Exp. Ophthalmol., 235, 130-135.
88. 1-agonist 5-CT intraocular pressure in rabbits. Invest. Ophthalmol. Vis. Sci., 34, 3035-3042.
89. Mitchell, C.K., Redburn, D.A. (1985) Analysis of pre- and post-synaptic factors of the serotonin system in rabbit retina. J. Cell Biol., 100, 64-73.
90. Monsma, F.J. Jr., Shen, Y., Ward, R.P., Hamblin, M.W., Sibley, D.R. (1993) Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol. Pharmacol., 43, 320-327.
91. Moro, F., Scapagnini, U., Scaletta, S., Drago, F. (1981) Serotonin nerve endings and regulation of pupillary diameter. Ann. Ophthalmol., 13, 487-490.
92. Morrison, J.C., Freddo, T.F. (1996) Anatomy, microcirculation, and ultrastructure of the ciliary body. In: Ritch, R., Shields, M.B., Krupin, T., Eds. The glaucomas: clinical science (2nd edition). St. Louis: Mosbly-Year Book, Inc., Vol. 1; pp. 125-138.
93. Murray, C.J., Lopez, A.D. (1999) On the comparable quantification of health risks: lessons from the Global Burden of Disease Study. Epidemiology, 10, 594-605.
94. Nash, M.S., Flanigan, T., Leslie, R. Osborne, N.N. (1999) Serotonin-2A receptor mRNA expression in rat retinal pigment epithelial cells. Ophthalmic Res., 31, 1-4.
95. 1A receptors associated with human retinal pigment epithelial cells in culture. Invest. Ophthalmol. Vis. Sci., 38, 510-519.
96. Nash, M.S., Wood, J.P., Osborne, N.N. (1997) Protein kinase C activation by serotonin potentiates agonist-induced stimulation of cAMP production in cultured rat retinal pigment epithelial cells. Exp. Eye Res., 64, 249-255.
97. Neufeld, A.H., Jumblatt, M.M., Esser, K.A., Cintron, C., Beuerman, R.W. (1984) Beta-adrenergic and serotonergic stimulation of rabbit corneal tissues and cultured cells. Invest. Ophthalmol. Vis. Sci., 25, 1235-1239.
98. Neufeld, A.H., Ledgard, S.E., Jumblatt, M.M., Klyce, S.D. (1982) Serotonin-stimulated cyclic AMP synthesis in the rabbit corneal epithelium. Invest. Ophthalmol. Vis. Sci., 23, 193-198.
99. Neufeld, A.H., Ledgard, S.E,. Yoza, B.K. (1983) Changes in responsiveness of the beta-adrenergic and serotonergic pathways of the rabbit corneal epithelium. Invest. Ophthalmol. Vis. Sci., 24, 527-534.
100. Olver, J.M. (1998) Angioarchitecture of the human optic nerve and perioptic area. In: Bisantis, C., Carella, G., Eds. Vascular system of the optic nerve and perioptic area. Italian Society of Ophthalmology (SOI); Rome: I.N.C. Innovation-News-Communication, pp. 29-43
101. Osborne, N.N. (1982) Assay, distribution and function of serotonin in nervous tissue. In: Osborne, N.N., Ed. Biology of serotoninergic transmission. Chichester: J Wiley & Sons Inc., pp. 7-27.
102. Osborne, N.N. (1983) The occurrence of serotonergic nerves in the bovine cornea. Neurosci. Lett., 35, 15-18.
103. Osborne, N.N. (1984) Indoleamines in the eye with special reference to the serotonergic neurones of the retina. In: Osborne, N.N., Chader, J., Eds. Progress in retinal research. Oxford: Pergamon Press, Vol. 3; pp. 61-103.
104. Osborne, N.N., Chidlow, G., Nash, M.S., Wood, J.P. (1999) The potential of neuroprotection in glaucoma treatment. Curr. Opin. Ophthalmol., 10, 82-92.
105. 1A receptors have similar functions in the control of intraocular pressure in the rabbit? Ophthalmologica, 210, 308-314.
106. 1a receptors positively coupled to C-AMP formation in the rabbit retina. Neurochem. Int., 19, 407-411.
107. Osborne, N.N., Melena, J., Chidlow, G., Wood, J.P. (2001) A hypothesis to explain ganglion cell death caused by vascular insults at the optic nerve head: possible implication for the treatment of glaucoma. Br. J. Ophthalmol., 85, 1252-1259.
108. Osborne, N.N., Meyer-Bothling, U., Barnett, N.L. (1994) Serotonin receptors in the eye. In: Anderson, D.R., Drance, S.M., Eds. Encounters in glaucoma research 1: receptor biology and glaucoma. Milan: Fogliazza Editore, pp. 331-364.
109. Osborne, N.N., Tobin, AB. (1987) Serotonin-accumulating cells in the iris-ciliary body and cornea of various species. Exp. Eye Res., 44, 731-745.
110. 1A agonists: Potential use in glaucoma. Evidence from animal studies. Eye, 14, 454-463.
111. Palmberg, P. (1996) Gonioscopy. In: The glaucomas: clinical science. Ritch, R., Shields, M.B., Krupin, T. Eds. St. Louis: Mosbly-Year Book, Inc., (Vol. 1) (2nd edition), pp. 455-469.
112. Peroutka, S.J. (1988) 5-hydroxytryptamine receptor subtypes. Ann. Rev. Neurosci., 11, 45-60.
113. Peroutka, S.J. (1991) The molecular pharmacology of 5-hydroxytryptamine receptor subtypes. In: Peroutka, S.J., Ed. Serotonin receptor subtypes: basic and clinical aspects. New York: Wiley-Liss, pp. 65-80.
114. Phelps, C.D,. Woodson, R.F., Kolker, A.E. (1974) Diurnal variation in intraocular pressure. Am. J. Ophthalmol., 77, 367-377.
115. (7) receptor expression in the mammalian retina. Brain Res., 875, 152-156.
116. (3B) receptor subunits in mammalian retinae: Potential presynaptic modulators of photoreceptors. Brain Res., 896, 77-85.
117. 2a receptors in the rabbit retina: potential presynaptic modulators. Vis. Neurosci., 16, 221-230.
118. Quigley, H.A., Addicks, E.M. (1980) Chronic experimental glaucoma in primates. II Effect of extended intraocular pressure elevation on optic nerve head and axonal transport. Invest. Ophthalmol. Vis. Sci., 19, 137-152.
119. Rapport, M.M., Green, A.A., Page, I.H. (1948) Serum vasoconstrictor (serotonin) IV. Isolation and characterization. J. Biol. Chem., 176, 1243-1251.
120. Ritch, R., Lowe, R.F. (1996) Angle-closure glaucoma: clinical types. In: Ritch, R., Shields, M.B., Krupin, T. Eds. The glaucomas: clinical science St. Louis: Mosbly-Year Book, Inc., (2nd edition), Vol. 2; pp. 821-840.
121. Rottmann, C.N. (2007) SSRIs and the syndrome of inappropriate antidiuretic hormone secretion. Am. J. Nurs., 107, 51-58.
122. 7) activating cAMP formation. Proc. Natl. Acad. Sci., 90, 8547-8551.
123. Saletu, B., Grünberger, J. (1988) Drug profiling by computed electroencephalography and brain maps, with special consideration of sertraline and its psychometric effects. J. Clin. Psychiatry, 49, 59-71.
124. Sanders-Bush, E., Mayer, S.E. (2001) 5-hydroxytryptamine (serotonin): receptor, agonists and antagonists. In: Goodman Gilman, A., Hardman, J.G., Limbird, L.E., Eds. Goodman & Gilman's The pharmacological basis of therapeutics (10th edition). New York: McGraw-Hill Medical Publishing Division, pp. 269-290.
125. Schmitt, J.A, Riedel, W.J., Vuurman, E.F., Kruizinga, M., Ramaekers, J.G. (2002) Modulation of the critical flicker fusion effects of serotonin reuptake inhibitors by concomitant pupillary changes. Psychopharmacology, 160, 381-386.
126. Schoenwald, R.D., Gadiraju, R.R, Barfknecht, C.F. (1997) Serotonin antagonists for use as antiglaucoma agents and their ocular penetration. Eur. J. Pharm. Biopharm., 43, 273-281.
127. Scullica, L. (1996) Anatomic-functional aspects of aqueous humor inflow. In: Bucci, M.G., Ed. Glaucoma: decision making in therapy. Milan: Springer-Verlag, pp. 3-8.
128. Sener, E.C, Kiratli, H. (2001) Presumed sertraline maculopathy. Acta Ophthalmol. Scand., 79, 428-30.
129. Sharif, N.A., Senchyna, M. (2006) Serotonin receptor subtype mRNA expression in human ocular tissues, determined by RT-PCR. Mol. Vis., 12, 1040-1047.
130. Shields,. MB., Ritch, R., Krupinm. T. (1996) Classifications of the glaucomas. In: Ritch R, Shields MB, Krupin T, editors. The glaucomas: clinical science St. Louis: Mosbly-Year Book, Inc., (2nd edition), Vol. 2; pp. 717-725.
131. Shimidzu. T., Itoh. Y., Tatsumi, S., Hayashi. S., Ukai. Y., Yoshikuni, Y., Kimura, K. (1997) Blockade of voltage-sensitive sodium channels by NS-7, a novel neuroprotective compound, in the rat brain. Naunyn Schmiedebergs Arch. Pharmacol., 355, 601-608.
132. Somer, E., Snyderman, N.L. (1999) Food and mood: the complete guide to eating well and feeling your best (2nd edition). New York: Henry Holt & Company, Inc.
133. Stary, H.C. (1989) Evolution and progression of atherosclerotic lesions in coronary arteries in children and young adults. Atherosclerosis. 99, 19-32.
134. + channels as target for neuroprotective drugs. Trends Pharmacol. Sci., 16, 309-316.
135. 2 receptor agonist, induces renal vasodilation via nitric oxide in anesthetized dogs. Eur. J. Pharmacol., 437, 79-84.
136. Tobin, A.B., Osborne, N.N. (1989) Evidence for the presence of serotonin receptors negatively coupled to adenylate cyclase in the rabbit iris-ciliary body. J. Neurochem., 53, 686-691.
137. Tobin, A.B., Unger, W., Osborne, N.N. (1988) Evidence for the presence of serotonergic neurons and receptors in the iris-ciliary body complex of the rabbit. J. Neurosci., 8, 3713-3721.
138. Uusitalo, H., Lehtosalo, J., Laakso, J., Härkonen, M., Palkama, A. (1982) Immunocytochemical and biochemical evidence for 5-hydroxytryptamine containing nerves in the anterior part of the eye. Exp. Eye Res., 35, 671-675.
139. Van, Wijngaarden, I., Tulp, M.T., Soudijn, W. (1990) The concept of selectivity in 5-HT receptor research. Eur. J. Pharmacol., 188, 301-312.
140. Vivekanandan, S., Lou, M.F. (1989) Evidence for the presence of phosphoinositide cycle and its involvement in cellular signal transduction in the rabbit lens. Curr. Eye Res., 8, 101-111.
141. von Bahr, C., Ursing, C., Yasui, N., Tybring, G., Bertilsson, L., Röjdmark, S. (2000) Fluvoxamine but not citalopram increases serum melatonin in healthy subjects - an indication that cytochrome P450 CYP1A2 and CYP2C19 hydroxylate melatonin. Eur. J. Clin. Pharmacol., 56, 123-7.
142. von Moltke, L.L., Greenblatt, D.J., Giancarlo, G.M., Granda, B.W., Harmatz, J.S., Shader, R.I. (2001) Escitalopram (S-citalopram) and its metabolites in vitro: cytochromes mediating biotransformation, inhibitory effects, and comparison to R-citalopram. Drug Metab. Dispos., 29, 1102-9.
143. Wiederholt, M., Sturm, A., Lepple-Wienhues, A. (1994) Relaxation of trabecular meshwork and ciliary muscle by release of nitric oxide. Invest. Ophthalmol. Vis. Sci., 35, 2515-20.
144. Yan, D.B., Coloma, F.M., Metheetrairut, A., Trope, G.E., Heathcote, J.G., Ethier, C.R. (1994) Deformation of the lamina cribrosa by elevated intraocular pressure. Br. J. Ophthalmol., 78, 643-8.
145. Zelefskym, J.R., Fine, H.F., Rubinstein, V.J., Hsu, I, S., Finger, P.T. (2006) Escitalopram-induced uveal effusions and bilateral angle closure glaucoma. Am. J. Ophthalmol., 141, 1144-7.